English

Harvard Apparatus Regenerative Technology, Inc.

EDGAR

BSTG Quarterly report (10-Q) · filed 2026-08-13

Annual consolidated revenue for 2025: about USD 704K, using the latest reported figures. The previous period, 2024, was about USD 430K.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

414 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 414000 USD Source

Operating margin

-408.7%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -1692000 USD Source
Revenue: 414000 USD Source

Operating cash flow

-569 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1506000 USD Source
Operating Cash Flow: -937000 USD Source

Cash and cash equivalents: 400 thousand USD 2026-06-30 Source
Exact value

400000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 17.6 million shares 2026-06-30 Source
Exact value

17580744 shares

Reported share-count change

10.44% · 1.66 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

15918979 shares · 2025-06-30· Source
17580744 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2025-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 7 of 11 periods available· newest 2024-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+63.7%

Prior period

USD 430,000

2024-01-01 – 2024-12-31
Current period

USD 704,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

704000 − 430000 = 274000 USD

430000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
704000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Harvard Apparatus Regenerative Technology, Inc. · 2025-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Year-over-year change in Revenue: 274000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 704000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#1313595 Filing: 000143774926009079 Input fundies:Revenue: 430000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#1337485 Filing: 000143774926009079
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 863,000

Prior period

−USD 7.73 million

2024-01-01 – 2024-12-31
Current period

−USD 6.87 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-6869000 − -7732000 = 863000 USD

-7732000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-6869000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Harvard Apparatus Regenerative Technology, Inc. · 2025-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Year-over-year change in Net income: 863000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6869000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#1329954 Filing: 000143774926009079 Input fundies:NetIncome: -7732000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#1353824 Filing: 000143774926009079
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.02 million

Prior period

−USD 4.85 million

2024-01-01 – 2024-12-31
Current period

−USD 3.83 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-3828000 − -4852000 = 1024000 USD

-4852000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-3828000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Harvard Apparatus Regenerative Technology, Inc. · 2025-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Year-over-year change in Operating cash flow: 1024000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3828000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#847777 Filing: 000143774926009079 Input fundies:OperatingCashFlow: -4852000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#848575 Filing: 000143774926009079
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 704,000 100% of revenue
Operating costs Derived USD 7.62 million 1,082% of revenue
Operating income −USD 6.92 million −982% of revenue
Tax, interest and other Derived −USD 46,000 −6.5% of revenue
Net income −USD 6.87 million −976% of revenue

Cash

Operating cash flow −USD 3.83 million −544% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 10,016% of revenue.
2016 Operating loss: operating costs were 14,888% of revenue.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2023 Operating loss: operating costs were 8,828% of revenue.
2024 Operating loss: operating costs were 1,897% of revenue.
2025 Operating loss: operating costs were 1,082% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	118000	11819000 Derived	-11701000	3000 Derived	-11704000	-7362000 Derived	Source 2015-01-01 – 2015-12-31: 118000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -11701000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -11704000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -7186000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 176000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	82000	12208000 Derived	-12126000	-547000 Derived	-11579000	-9360000 Derived	Source 2016-01-01 – 2016-12-31: 82000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -12126000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -11579000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -9058000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 302000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	0	11468000 Derived	-11468000	448000 Derived	-11916000	-11150000 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -11468000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -11916000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -11014000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 136000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	0	7841000 Derived	-7841000	-312000 Derived	-7529000	-7769000 Derived	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -7841000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -7529000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -7638000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 131000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	103000	9093000 Derived	-8990000	-45000 Derived	-8945000	-6950000 Derived	Source 2023-01-01 – 2023-12-31: 103000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -8990000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -8945000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -6939000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 11000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	430000	8156000 Derived	-7726000	6000 Derived	-7732000	-4852000 Derived	Source 2024-01-01 – 2024-12-31: 430000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -7726000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -7732000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -4852000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: -0 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	704000	7619000 Derived	-6915000	-46000 Derived	-6869000	Unavailable	Source 2025-01-01 – 2025-12-31: 704000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -6915000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -6869000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -3828000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 704K 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	118000	Revenue: 118000 Open source
20162016-12-31	Revenue	82000	Revenue: 82000 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	0	Revenue: 0 Open source
20232023-12-31	Revenue	103000	Revenue: 103000 Open source
20242024-12-31	Revenue	430000	Revenue: 430000 Open source
20252025-12-31	Revenue	704000	Revenue: 704000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

63.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 118000 Open source
20162016-12-31	Year over year	-30.5%	Revenue: 82000 Open source Revenue: 118000 Open source
20172017-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 82000 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20232023-12-31	Year over year	No prior comparable period	Revenue: 103000 Open source
20242024-12-31	Year over year	317.5%	Revenue: 430000 Open source Revenue: 103000 Open source
20252025-12-31	Year over year	63.7%	Revenue: 704000 Open source Revenue: 430000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -982.2% 2025

Net margin -975.7% 2025

Free cash flow margin -1,128.4% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-9,916.1%	Operating Income: -11701000 Open source Revenue: 118000 Open source
20162016-12-31	Operating margin	-14,787.8%	Operating Income: -12126000 Open source Revenue: 82000 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -11468000 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	Not reported	Operating Income: -7841000 Open source Revenue: 0 Open source
20232023-12-31	Operating margin	-8,728.2%	Operating Income: -8990000 Open source Revenue: 103000 Open source
20242024-12-31	Operating margin	-1,796.7%	Operating Income: -7726000 Open source Revenue: 430000 Open source
20252025-12-31	Operating margin	-982.2%	Operating Income: -6915000 Open source Revenue: 704000 Open source
20152015-12-31	Net margin	-9,918.6%	Net Income: -11704000 Open source Revenue: 118000 Open source
20162016-12-31	Net margin	-14,120.7%	Net Income: -11579000 Open source Revenue: 82000 Open source
20172017-12-31	Net margin	Not reported	Net Income: -11916000 Open source Revenue: 0 Open source
20182018-12-31	Net margin	Not reported	Net Income: -7529000 Open source Revenue: 0 Open source
20232023-12-31	Net margin	-8,684.5%	Net Income: -8945000 Open source Revenue: 103000 Open source
20242024-12-31	Net margin	-1,798.1%	Net Income: -7732000 Open source Revenue: 430000 Open source
20252025-12-31	Net margin	-975.7%	Net Income: -6869000 Open source Revenue: 704000 Open source
20152015-12-31	Free cash flow margin	-6,239%	Revenue: 118000 Open source Operating Cash Flow: -7186000 Open source Capital Expenditure: 176000 Open source
20162016-12-31	Free cash flow margin	-11,414.6%	Revenue: 82000 Open source Operating Cash Flow: -9058000 Open source Capital Expenditure: 302000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -11014000 Open source Capital Expenditure: 136000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -7638000 Open source Capital Expenditure: 131000 Open source
20232023-12-31	Free cash flow margin	-6,747.6%	Revenue: 103000 Open source Operating Cash Flow: -6939000 Open source Capital Expenditure: 11000 Open source
20242024-12-31	Free cash flow margin	-1,128.4%	Revenue: 430000 Open source Operating Cash Flow: -4852000 Open source Capital Expenditure: -0 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 704000 Open source Operating Cash Flow: -3828000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.8M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-7186000	Operating Cash Flow: -7186000 Open source
20162016-12-31	Operating cash flow	-9058000	Operating Cash Flow: -9058000 Open source
20172017-12-31	Operating cash flow	-11014000	Operating Cash Flow: -11014000 Open source
20182018-12-31	Operating cash flow	-7638000	Operating Cash Flow: -7638000 Open source
20232023-12-31	Operating cash flow	-6939000	Operating Cash Flow: -6939000 Open source
20242024-12-31	Operating cash flow	-4852000	Operating Cash Flow: -4852000 Open source
20252025-12-31	Operating cash flow	-3828000	Operating Cash Flow: -3828000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.9M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	-7362000	Operating Cash Flow: -7186000 Open source Capital Expenditure: 176000 Open source
20162016-12-31	Free cash flow	-9360000	Operating Cash Flow: -9058000 Open source Capital Expenditure: 302000 Open source
20172017-12-31	Free cash flow	-11150000	Operating Cash Flow: -11014000 Open source Capital Expenditure: 136000 Open source
20182018-12-31	Free cash flow	-7769000	Operating Cash Flow: -7638000 Open source Capital Expenditure: 131000 Open source
20232023-12-31	Free cash flow	-6950000	Operating Cash Flow: -6939000 Open source Capital Expenditure: 11000 Open source
20242024-12-31	Free cash flow	-4852000	Operating Cash Flow: -4852000 Open source Capital Expenditure: -0 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: -3828000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

60.5% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	7.3%	Total Liabilities: 654000 Open source Total Assets: 8956000 Open source
20162016-12-31	Liabilities / assets	61%	Total Liabilities: 2777000 Open source Total Assets: 4551000 Open source
20172017-12-31	Liabilities / assets	32.2%	Total Liabilities: 1622000 Open source Total Assets: 5045000 Open source
20182018-12-31	Liabilities / assets	25.1%	Total Liabilities: 662000 Open source Total Assets: 2633000 Open source
20232023-12-31	Liabilities / assets	37%	Total Liabilities: 968000 Open source Total Assets: 2614000 Open source
20242024-12-31	Liabilities / assets	27.5%	Total Liabilities: 1220000 Open source Total Assets: 4442000 Open source
20252025-12-31	Liabilities / assets	60.5%	Total Liabilities: 1620000 Open source Total Assets: 2677000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.19× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	12.05×	Current Assets: 7882000 Open source Current Liabilities: 654000 Open source
20162016-12-31	Current assets / current liabilities	1.26×	Current Assets: 3486000 Open source Current Liabilities: 2777000 Open source
20172017-12-31	Current assets / current liabilities	2.72×	Current Assets: 4413000 Open source Current Liabilities: 1622000 Open source
20182018-12-31	Current assets / current liabilities	3.25×	Current Assets: 2154000 Open source Current Liabilities: 662000 Open source
20232023-12-31	Current assets / current liabilities	0.81×	Current Assets: 783000 Open source Current Liabilities: 968000 Open source
20242024-12-31	Current assets / current liabilities	3.17×	Current Assets: 3234000 Open source Current Liabilities: 1021000 Open source
20252025-12-31	Current assets / current liabilities	1.19×	Current Assets: 1829000 Open source Current Liabilities: 1534000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 11.7 million Exact value Exact value: -11704000 USD 2015-01-01 – 2015-12-31: -11704000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2015-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -11704000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11704000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420417015232/bstg-20161231.xml#67796 Filing: 000114420417015232 The citation records this snapshot. The page link may show a newer release later.	−USD 7.19 million Exact value Exact value: -7186000 USD 2015-01-01 – 2015-12-31: -7186000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2015-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -7186000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7186000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420417015232/bstg-20161231.xml#101050 Filing: 000114420417015232 The citation records this snapshot. The page link may show a newer release later.	USD 176,000 Exact value Exact value: 176000 USD 2015-01-01 – 2015-12-31: 176000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Harvard Apparatus Regenerative Technology, Inc. · 2015-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Capital Expenditure: 176000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 176000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420417015232/bstg-20161231.xml#101484 Filing: 000114420417015232 The citation records this snapshot. The page link may show a newer release later.	−USD 7.36 million Calculation and evidence -7186000 − 176000 USD Exact free cash flow: -7362000 USD 2015-01-01 – 2015-12-31: -7186000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 176000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Harvard Apparatus Regenerative Technology, Inc. · 2015-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Free cash flow: -7362000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7186000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420417015232/bstg-20161231.xml#101050 Filing: 000114420417015232 Input fundies:CapitalExpenditure: 176000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420417015232/bstg-20161231.xml#101484 Filing: 000114420417015232 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 11.58 million Exact value Exact value: -11579000 USD 2016-01-01 – 2016-12-31: -11579000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2016-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -11579000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11579000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420418018969/bstg-20171231.xml#86772 Filing: 000114420418018969 The citation records this snapshot. The page link may show a newer release later.	−USD 9.06 million Exact value Exact value: -9058000 USD 2016-01-01 – 2016-12-31: -9058000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2016-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -9058000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9058000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420418018969/bstg-20171231.xml#128901 Filing: 000114420418018969 The citation records this snapshot. The page link may show a newer release later.	USD 302,000 Exact value Exact value: 302000 USD 2016-01-01 – 2016-12-31: 302000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Harvard Apparatus Regenerative Technology, Inc. · 2016-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Capital Expenditure: 302000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 302000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420418018969/bstg-20171231.xml#129295 Filing: 000114420418018969 The citation records this snapshot. The page link may show a newer release later.	−USD 9.36 million Calculation and evidence -9058000 − 302000 USD Exact free cash flow: -9360000 USD 2016-01-01 – 2016-12-31: -9058000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 302000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Harvard Apparatus Regenerative Technology, Inc. · 2016-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Free cash flow: -9360000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9058000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420418018969/bstg-20171231.xml#128901 Filing: 000114420418018969 Input fundies:CapitalExpenditure: 302000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420418018969/bstg-20171231.xml#129295 Filing: 000114420418018969 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 11.92 million Exact value Exact value: -11916000 USD 2017-01-01 – 2017-12-31: -11916000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2017-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -11916000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11916000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#2051942 Filing: 000114420419017039 The citation records this snapshot. The page link may show a newer release later.	−USD 11.01 million Exact value Exact value: -11014000 USD 2017-01-01 – 2017-12-31: -11014000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2017-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -11014000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11014000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#86357 Filing: 000114420419017039 The citation records this snapshot. The page link may show a newer release later.	USD 136,000 Exact value Exact value: 136000 USD 2017-01-01 – 2017-12-31: 136000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Harvard Apparatus Regenerative Technology, Inc. · 2017-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Capital Expenditure: 136000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 136000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#86764 Filing: 000114420419017039 The citation records this snapshot. The page link may show a newer release later.	−USD 11.15 million Calculation and evidence -11014000 − 136000 USD Exact free cash flow: -11150000 USD 2017-01-01 – 2017-12-31: -11014000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 136000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Harvard Apparatus Regenerative Technology, Inc. · 2017-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Free cash flow: -11150000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11014000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#86357 Filing: 000114420419017039 Input fundies:CapitalExpenditure: 136000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#86764 Filing: 000114420419017039 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 7.53 million Exact value Exact value: -7529000 USD 2018-01-01 – 2018-12-31: -7529000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2018-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -7529000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7529000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#2051796 Filing: 000114420419017039 The citation records this snapshot. The page link may show a newer release later.	−USD 7.64 million Exact value Exact value: -7638000 USD 2018-01-01 – 2018-12-31: -7638000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2018-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -7638000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7638000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#86153 Filing: 000114420419017039 The citation records this snapshot. The page link may show a newer release later.	USD 131,000 Exact value Exact value: 131000 USD 2018-01-01 – 2018-12-31: 131000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Harvard Apparatus Regenerative Technology, Inc. · 2018-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Capital Expenditure: 131000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 131000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#86562 Filing: 000114420419017039 The citation records this snapshot. The page link may show a newer release later.	−USD 7.77 million Calculation and evidence -7638000 − 131000 USD Exact free cash flow: -7769000 USD 2018-01-01 – 2018-12-31: -7638000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 131000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Harvard Apparatus Regenerative Technology, Inc. · 2018-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Free cash flow: -7769000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7638000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#86153 Filing: 000114420419017039 Input fundies:CapitalExpenditure: 131000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000114420419017039/bstg-20181231.xml#86562 Filing: 000114420419017039 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 7.98 million Exact value Exact value: -7978000 USD 2021-01-01 – 2021-12-31: -7978000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2021-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -7978000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7978000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000149315223009840/form10-k.htm#1697527 Filing: 000149315223009840 The citation records this snapshot. The page link may show a newer release later.	−USD 2.63 million Exact value Exact value: -2628000 USD 2021-01-01 – 2021-12-31: -2628000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2021-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -2628000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2628000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000149315223009840/form10-k.htm#1213230 Filing: 000149315223009840 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 6.07 million Exact value Exact value: -6073000 USD 2022-01-01 – 2022-12-31: -6073000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2022-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -6073000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6073000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000149315224011784/form10-k.htm#1228260 Filing: 000149315224011784 The citation records this snapshot. The page link may show a newer release later.	−USD 5.11 million Exact value Exact value: -5106000 USD 2022-01-01 – 2022-12-31: -5106000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2022-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -5106000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5106000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000149315224011784/form10-k.htm#885517 Filing: 000149315224011784 The citation records this snapshot. The page link may show a newer release later.	USD 5,000 Exact value Exact value: 5000 USD 2022-01-01 – 2022-12-31: 5000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Harvard Apparatus Regenerative Technology, Inc. · 2022-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Capital Expenditure: 5000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000149315224011784/form10-k.htm#889180 Filing: 000149315224011784 The citation records this snapshot. The page link may show a newer release later.	−USD 5.11 million Calculation and evidence -5106000 − 5000 USD Exact free cash flow: -5111000 USD 2022-01-01 – 2022-12-31: -5106000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 5000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Harvard Apparatus Regenerative Technology, Inc. · 2022-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Free cash flow: -5111000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5106000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000149315224011784/form10-k.htm#885517 Filing: 000149315224011784 Input fundies:CapitalExpenditure: 5000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000149315224011784/form10-k.htm#889180 Filing: 000149315224011784 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 8.95 million Exact value Exact value: -8945000 USD 2023-01-01 – 2023-12-31: -8945000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2023-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -8945000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8945000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774925010213/hrgn20241231_10k.htm#1329454 Filing: 000143774925010213 The citation records this snapshot. The page link may show a newer release later.	−USD 6.94 million Exact value Exact value: -6939000 USD 2023-01-01 – 2023-12-31: -6939000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2023-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -6939000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6939000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774925010213/hrgn20241231_10k.htm#901939 Filing: 000143774925010213 The citation records this snapshot. The page link may show a newer release later.	USD 11,000 Exact value Exact value: 11000 USD 2023-01-01 – 2023-12-31: 11000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Harvard Apparatus Regenerative Technology, Inc. · 2023-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Capital Expenditure: 11000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774925010213/hrgn20241231_10k.htm#909751 Filing: 000143774925010213 The citation records this snapshot. The page link may show a newer release later.	−USD 6.95 million Calculation and evidence -6939000 − 11000 USD Exact free cash flow: -6950000 USD 2023-01-01 – 2023-12-31: -6939000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 11000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Harvard Apparatus Regenerative Technology, Inc. · 2023-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Free cash flow: -6950000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6939000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774925010213/hrgn20241231_10k.htm#901939 Filing: 000143774925010213 Input fundies:CapitalExpenditure: 11000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774925010213/hrgn20241231_10k.htm#909751 Filing: 000143774925010213 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 7.73 million Exact value Exact value: -7732000 USD 2024-01-01 – 2024-12-31: -7732000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2024-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -7732000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7732000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#1353824 Filing: 000143774926009079 The citation records this snapshot. The page link may show a newer release later.	−USD 4.85 million Exact value Exact value: -4852000 USD 2024-01-01 – 2024-12-31: -4852000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2024-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -4852000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4852000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#848575 Filing: 000143774926009079 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: -0 USD 2024-01-01 – 2024-12-31: -0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Harvard Apparatus Regenerative Technology, Inc. · 2024-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Capital Expenditure: -0 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: -0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774925010213/hrgn20241231_10k.htm#908923 Filing: 000143774925010213 The citation records this snapshot. The page link may show a newer release later.	−USD 4.85 million Calculation and evidence -4852000 − -0 USD Exact free cash flow: -4852000 USD 2024-01-01 – 2024-12-31: -4852000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: -0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Harvard Apparatus Regenerative Technology, Inc. · 2024-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Free cash flow: -4852000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4852000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#848575 Filing: 000143774926009079 Input fundies:CapitalExpenditure: -0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774925010213/hrgn20241231_10k.htm#908923 Filing: 000143774925010213 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 6.87 million Exact value Exact value: -6869000 USD 2025-01-01 – 2025-12-31: -6869000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Harvard Apparatus Regenerative Technology, Inc. · 2025-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Net Income: -6869000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6869000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#1329954 Filing: 000143774926009079 The citation records this snapshot. The page link may show a newer release later.	−USD 3.83 million Exact value Exact value: -3828000 USD 2025-01-01 – 2025-12-31: -3828000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Harvard Apparatus Regenerative Technology, Inc. · 2025-12-31 Harvard Apparatus Regenerative Technology, Inc. (edgar:1563665) Operating Cash Flow: -3828000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:41:13Z Snapshot: 33d45c0fb68411733b122a29f6efb3ec911aca3ac8d67e7d4fb1c79ebcce2831 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563665/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3828000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563665/000143774926009079/hrgn20251231_10k.htm#847777 Filing: 000143774926009079 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

63 filings · 3,858 latest values · 3,858 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001563665, 1563665, BSTG, HART, HRGN, edgar:1563665

Also known as BIOSTAGE, INC., BIOSTAGE, INC., Biostage, Inc., HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC., Harvard Apparatus Regenerative Technology, Inc.

Harvard Apparatus Regenerative Technology, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation